AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 137.1 SEK 0.22% Market Closed
Market Cap: 16.7B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AddLife AB
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Deferred Income Tax
kr415m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Deferred Income Tax
kr224.5m
CAGR 3-Years
56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Deferred Income Tax
kr187m
CAGR 3-Years
72%
CAGR 5-Years
43%
CAGR 10-Years
57%
G
Genovis AB
STO:GENO
Deferred Income Tax
kr2m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Deferred Income Tax
kr62.9m
CAGR 3-Years
18%
CAGR 5-Years
19%
CAGR 10-Years
9%
M
Magle Chemoswed Holding AB
STO:MAGLE
Deferred Income Tax
kr8.6m
CAGR 3-Years
60%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

AddLife AB
Glance View

Market Cap
16.7B SEK
Industry
Life Sciences Tools & Services

AddLife AB, a prominent player in the life sciences sector, intricately weaves its narrative through a commitment to enhancing healthcare and laboratory services across Europe. Founded in Sweden, the company has established itself as a crucial intermediary, effectively bridging the gap between manufacturers of medical devices and the healthcare institutions that require them. AddLife operates by acquiring and developing niche companies within two core segments: Labtech and Medtech. Through Labtech, it supplies essential equipment, instruments, and consumables for diagnostic and research laboratories. In Medtech, it provides a variety of healthcare logistics, medical products, and services to hospitals and care facilities, enhancing their operational efficiencies. The financial heartbeat of AddLife rests on its adeptness at creating value through strategic acquisitions and organic growth, capitalizing on the increasing demand for innovative healthcare solutions. By continuously expanding its product portfolio and enhancing the capabilities of its subsidiaries, AddLife ensures a diversified revenue stream, mitigating risks associated with dependence on any single product or market. This approach not only fortifies their market position but also fuels their profit margins, as they deftly respond to shifting industry demands and regulatory changes. The company's shared values and decentralized business model promote entrepreneurship within its subsidiaries, fostering an environment where innovation can thrive—ensuring their continued success and substantial contribution to the evolving landscape of healthcare.

ALIF B Intrinsic Value
158.23 SEK
Undervaluation 13%
Intrinsic Value
Price

See Also

What is AddLife AB's Deferred Income Tax?
Deferred Income Tax
415m SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Deferred Income Tax amounts to 415m SEK.

What is AddLife AB's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 3Y
37%

Over the last year, the Deferred Income Tax growth was -10%. The average annual Deferred Income Tax growth rates for AddLife AB have been 37% over the past three years .

Back to Top